ResearchMoz.us include new market research report" Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors " to its huge collection of research reports.
Competitor Analysis: Therapeutic Antibodies 2015: Biosimilars & Biosuperiors
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of April 2015.
Click Here To Read The Full Report With TOC
Total sales of recombinant therapeutic monoclonal antibodies originating from companies located in regulated markets reached US$ 82.2 bln (+8.6% vs previous year) in the year 2014.
The report lists specifically for each target the branded products with their 2014 sales and up-side indications in development, as well as biosuperior and biosimilar antibody drug candidates in development.
The report includes a compilation of currently active projects in research and development of biosimilar and biosuperior therapeutic antibodies against commercially and clinically validated targets:
VEGF
TNF
Her2
CD20
EGF-R
B7.1/B7.2 (CD80/CD86)
IL-6R
Alpha4/beta1/7 integrin
IgE
RSV
RANKL
Complement C5
IL-12/IL-23
CD52
TNF
Her2
CD20
EGF-R
B7.1/B7.2 (CD80/CD86)
IL-6R
Alpha4/beta1/7 integrin
IgE
RSV
RANKL
Complement C5
IL-12/IL-23
CD52
All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html
Competitor projects are listed in a tabular format providing information on:
Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Company,
Product Category,
Indication,
R&D Stage and
additional comments with a hyperlink leading to the source of information.
Target / Mechanism of Action,
Class of Compound,
Company,
Product Category,
Indication,
R&D Stage and
additional comments with a hyperlink leading to the source of information.
0 comments:
Post a Comment